Table 1 General characteristics of included studies.
Study | Country | Region | Country income level | Economic evaluation type | Approach | Perspective | Time horizon (years) | Discount rate (costs and outcomes) | |
|---|---|---|---|---|---|---|---|---|---|
1. | Yang et al. [2021] 10 | China | WPR | Upper-MIC | CUA | Pairwise & Scenario-based | Third-Party Payer | 5, 10, 15 | 5% |
2. | Bayani et al. [2021] 18 | Philippines | SEAR | Lower-MIC | CUA | Scenario-based | Public Healthcare & Societal | Lifetime | 3% |
3. | Moradpour et al. [2020] 11 | Iran | EMR | Lower-MIC | CUA | Pairwise | Societal | Lifetime | 6% |
4. | Rosselli et al. [2015] 47 | Columbia | AMR | Upper-MIC | CUA&CEA | Pairwise | Third-Party Payer | 1, 2, 3, 5 | 3% |
5. | Jensen et al. [2014] 43 | Denmark | EUR | HIC | CUA | Pairwise | Public Healthcare | 6 | 3.5% |
6. | Villa et al. [2012] 19 | Spain | EUR | HIC | CUA | Scenario-based | Societal | 5, 10, 15 | 3.5% |
7. | Shimizu et al. [2012] 50 | Japan | WPR | HIC | CUA | Scenario-based | Public Healthcare | 15 | 3% |
8. | Haller et al. [2011] 46 | Austria | EUR | HIC | CUA&CEA | Scenario-based | Public Healthcare | 10 | 3% |
9. | Howard et al. [2009] 20 | Australia | WPR | HIC | CUA&CEA | Scenario-based | Public Healthcare | 5 | 5% |
10. | Kontodimopoulos et al. [2008] 44 | Greece | EUR | HIC | CUA | Pairwise | Public Healthcare | Lifetime | 5% |
11. | de Wit et al. [1998] 45 | Netherlands | EUR | HIC | CUA&CEA | Scenario-based | Societal | 5 | 5% |
12. | Arredondo et al. [1998] 48 | Mexico | AMR | Upper-MIC | CUA&CEA | Pairwise | Public Healthcare | 5 | 5% |
13. | Sesso et al. [1990] 49 | Brazil | AMR | Upper-MIC | CEA | Pairwise | Third-Party Payer | 2 | No discounting |